Journal of Clinical Endocrinology & Metabolism, Vol 81, 488-492, Copyright © 1996 by Endocrine Society

ARTICLES

Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: aldose reductase, glyoxalase I, and glyoxalase II--a clinical research center study

DM Ratliff, DJ Vander Jagt, RP Eaton and DL Vander Jagt
Department of Biochemistry, University of New Mexico School of Medicine, Albuquerque 87131, USA.

Levels of aldose reductase, glyoxalase I, and glyoxalase II in mononuclear and polymorphonuclear cells from insulin-dependent diabetes mellitus (IDDM) patients with long term diabetic complications were compared to levels in IDDM patients without complications and to those in nondiabetic controls. Cells were isolated from 22 asymptomatic long term IDDM patients, 22 symptomatic IDDM patients, and 16 controls, using a double gradient centrifugation procedure. Aldose reductase was determined by Western blots using polyclonal antiserum to human aldose reductase purified from skeletal muscle. Glyoxalase I and glyoxalase II were determined spectrophotometrically. Aldose reductase in mononuclear cells from symptomatic IDDM patients is significantly elevated compared to that in asymptomatic IDDM patients (mean +/- SEM, 0.96 +/- 0.20 vs. 0.46 +/- 0.08 microgram/mg protein; P < 0.02). Aldose reductase was not detected in polymorphonuclear cells. Glyoxalase I in mononuclear and polymorphonuclear cells from symptomatic IDDM patients is significantly elevated compared to that in controls [mean for mononuclear cells, 0.46 +/- 0.03 vs. 0.37 +/- 0.03 mumol/min.mg (P < 0.05); mean for polymorphonuclear cells, 0.16 +/- 0.01 vs. 0.10 +/- 0.01 mumol/min.mg (P < 0.002)]. Glyoxalase II is significantly elevated only in polymorphonuclear cells from symptomatic IDDM patients compared to controls (mean, 0.13 +/- 0.01 vs. 0.063 +/- 0.016 mumol/min.mg; P < 0.005). Glutathione peroxidase and glutathione S-transferase were not significantly different in these populations. Aldose reductase, glyoxalase I, and glyoxalase II are involved in the metabolism of methylglyoxal, suggesting that methylglyoxal may play a role in the etiology of diabetic complications.

This article has been cited by other articles:

				G. P. K. Marasinghe, I. M. Sander, B. Bennett, G. Periyannan, K.-W. Yang, C. A. Makaroff, and M. W. Crowder Structural Studies on a Mitochondrial Glyoxalase II J. Biol. Chem., December 9, 2005; 280(49): 40668 - 40675. [Abstract] [Full Text] [PDF]

				J. B. Ewaschuk, J. M. Naylor, and G. A. Zello D-Lactate in Human and Ruminant Metabolism J. Nutr., July 1, 2005; 135(7): 1619 - 1625. [Abstract] [Full Text] [PDF]

				P. J. Beisswenger, S. K. Howell, R. M. O’Dell, M. E. Wood, A. D. Touchette, and B. S. Szwergold {alpha}-Dicarbonyls Increase in the Postprandial Period and Reflect the Degree of Hyperglycemia Diabetes Care, April 1, 2001; 24(4): 726 - 732. [Abstract] [Full Text]

				D. J. McRobie, D. D. Glover, and T. S. Tracy Effects of Gestational and Overt Diabetes on Human Placental Cytochromes P450 and Glutathione S-Transferase Drug Metab. Dispos., April 1, 1998; 26(4): 367 - 371. [Abstract] [Full Text]

				F. A. Shamsi, A. Partal, C. Sady, M. A. Glomb, and R. H. Nagaraj Immunological Evidence for Methylglyoxal-derived Modifications in Vivo. DETERMINATION OF ANTIGENIC EPITOPES J. Biol. Chem., March 20, 1998; 273(12): 6928 - 6936. [Abstract] [Full Text] [PDF]

				C. Yabe-Nishimura Aldose Reductase in Glucose Toxicity: A Potential Target for the Prevention of Diabetic Complications Pharmacol. Rev., March 1, 1998; 50(1): 21 - 34. [Abstract] [Full Text] [PDF]

				V. O. Shah, R. I. Dorin, Y. Sun, M. Braun, and P. G. Zager Aldose Reductase Gene Expression Is Increased in Diabetic Nephropathy J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2294 - 2298. [Abstract] [Full Text] [PDF]